Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany.

导出 LinkOut

翻译打印收藏纠错

第一作者： Felicitas,Kühne

第一单位： Pfizer Pharma GmbH, Berlin, Germany.

作者： Felicitas,Kühne ^[1] ; Katharina,Achtert ^[2] ; Franziska,Püschner ^[2] ; Dominika,Urbanski-Rini ^[2] ; Juliane,Schiller ^[2] ; Ernestine,Mahar ^[1] ; Josephine,Friedrich ^[1] ; Mark,Atwood ^[3] ; Ralf,Sprenger ^[1] ; Jeffrey,Vietri ^[4] ; Christof,von Eiff ^[1] ; Christian,Theilacker ^[4]

作者单位： Pfizer Pharma GmbH, Berlin, Germany. ^[1] Private Institute for Applied Health Services Research (inav), Berlin, Germany. ^[2] Policy Analysis Inc, Boston, Massachusetts, USA. ^[3] Pfizer Inc, Collegeville, PA, USA. ^[4]

关键词 Germany Pneumococcal conjugate vaccine community acquired pneumonia cost-effectiveness pneumococcal disease

主题词成年人(Adult);人类(Humans);疫苗, 结合(Vaccines, Conjugate);费用效益分析(Cost-Benefit Analysis);肺炎球菌感染(Pneumococcal Infections);肺炎球菌菌苗(Pneumococcal Vaccines);肺炎链球菌(Streptococcus pneumoniae);接种(Vaccination);德国(Germany)

DOI 10.1080/14760584.2023.2262575

PMID 37881844

发布时间 2023-11-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert review of vaccines

921-932页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany.

Expert review of vaccines

相似文献

Expert review of vaccines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany.

Expert review of vaccines

相似文献

Expert review of vaccines

相关期刊

检索历史清除